- •Table of Contents
- •Copyright
- •Contributors
- •How to Use this Study Guide
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •4: Outcomes Research
- •Questions
- •Answers
- •5: Core Principles of Perioperative Care
- •Questions
- •Answers
- •Questions
- •Answers
- •7: Principles of Urologic Endoscopy
- •Questions
- •Answers
- •8: Percutaneous Approaches to the Upper Urinary Tract Collecting System
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •12: Infections of the Urinary Tract
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •15: Sexually Transmitted Diseases
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •20: Principles of Tissue Engineering
- •Questions
- •Answers
- •Questions
- •Answers
- •22: Male Reproductive Physiology
- •Questions
- •Answers
- •Questions
- •Answers
- •24: Male Infertility
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •28: Priapism
- •Questions
- •Answers
- •Questions
- •Answers
- •30: Surgery for Erectile Dysfunction
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •34: Neoplasms of the Testis
- •Questions
- •Answers
- •35: Surgery of Testicular Tumors
- •Questions
- •Answers
- •36: Laparoscopic and Robotic-Assisted Retroperitoneal Lymphadenectomy for Testicular Tumors
- •Questions
- •Answers
- •37: Tumors of the Penis
- •Questions
- •Answers
- •38: Tumors of the Urethra
- •Questions
- •Answers
- •39: Inguinal Node Dissection
- •Questions
- •Answers
- •40: Surgery of the Penis and Urethra
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •47: Renal Transplantation
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •50: Upper Urinary Tract Trauma
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •53: Strategies for Nonmedical Management of Upper Urinary Tract Calculi
- •Questions
- •Answers
- •54: Surgical Management for Upper Urinary Tract Calculi
- •Questions
- •Answers
- •55: Lower Urinary Tract Calculi
- •Questions
- •Answers
- •56: Benign Renal Tumors
- •Questions
- •Answers
- •57: Malignant Renal Tumors
- •Questions
- •Answers
- •Questions
- •Answers
- •59: Retroperitoneal Tumors
- •Questions
- •Answers
- •60: Open Surgery of the Kidney
- •Questions
- •Answers
- •Questions
- •Answers
- •62: Nonsurgical Focal Therapy for Renal Tumors
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •66: Surgery of the Adrenal Glands
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •71: Evaluation and Management of Women with Urinary Incontinence and Pelvic Prolapse
- •Questions
- •Answers
- •72: Evaluation and Management of Men with Urinary Incontinence
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •76: Overactive Bladder
- •Questions
- •Answers
- •77: Underactive Detrusor
- •Questions
- •Answers
- •78: Nocturia
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •82: Retropubic Suspension Surgery for Incontinence in Women
- •Questions
- •Answers
- •83: Vaginal and Abdominal Reconstructive Surgery for Pelvic Organ Prolapse
- •Questions
- •Answers
- •Questions
- •Answers
- •85: Complications Related to the Use of Mesh and Their Repair
- •Questions
- •Answers
- •86: Injection Therapy for Urinary Incontinence
- •Questions
- •Answers
- •87: Additional Therapies for Storage and Emptying Failure
- •Questions
- •Answers
- •88: Aging and Geriatric Urology
- •Questions
- •Answers
- •89: Urinary Tract Fistulae
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •92: Tumors of the Bladder
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •95: Transurethral and Open Surgery for Bladder Cancer
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •99: Orthotopic Urinary Diversion
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Answers
- •Questions
- •Answers
- •108: Prostate Cancer Tumor Markers
- •Questions
- •Answers
- •Questions
- •110: Pathology of Prostatic Neoplasia
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •114: Open Radical Prostatectomy
- •Questions
- •Answers
- •Questions
- •Answers
- •116: Radiation Therapy for Prostate Cancer
- •Questions
- •Answers
- •117: Focal Therapy for Prostate Cancer
- •Questions
- •Answers
- •Questions
- •Answers
- •119: Management of Biomedical Recurrence Following Definitive Therapy for Prostate Cancer
- •Questions
- •Answers
- •120: Hormone Therapy for Prostate Cancer
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •124: Perinatal Urology
- •Questions
- •Answers
- •Questions
- •Answers
- •126: Pediatric Urogenital Imaging
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •133: Surgery of the Ureter in Children
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •137: Vesicoureteral Reflux
- •Questions
- •Answers
- •138: Bladder Anomalies in Children
- •Questions
- •Answers
- •139: Exstrophy-Epispadias Complex
- •Questions
- •Answers
- •140: Prune-Belly Syndrome
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •144: Management of Defecation Disorders
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •147: Hypospadias
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •152: Adolescent and Transitional Urology
- •Questions
- •Answers
- •Questions
- •Answers
- •154: Pediatric Genitourinary Trauma
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
148
Etiology, Diagnosis, and Management
of Undescended Testis
Julia Spencer Barthold; Jennifer A. Hagerty
Questions
1.What is the master gene responsible for male sexual differentiation?
a.RSPO1
b.SOX9
c.WT1
d.SRY
e.WNT4
2.During male reproductive tract development, androgens mediate the differentiation of all of the following structures EXCEPT:
a.seminal vesicles.
b.ureter.
c.epididymis.
d.vas deferens.
e.ejaculatory ducts.
3.Which of the following does NOT play a direct role in testicular descent?
a.Testis
b.Epididymis
c.Genitofemoral nerve
d.Gubernaculum
e.Processus vaginalis
4.Peak levels of testosterone and insulin-like 3 (INSL 3) occur in the male fetus at approximately what gestational week?
a.5
b.8
c.10
d.15
e.20
5.Cryptorchidism increases the risk of all of the following EXCEPT:
a.spermatic cord torsion.
b.clinical hernia.
c.reactive hydrocele.
d.infertility.
e.testicular malignancy.
6.The risk of cryptorchidism is higher in all of the following syndromes EXCEPT:
a.cerebral palsy.
b.cystic fibrosis.
c.arthrogryposis.
d.prune-belly syndrome.
e.posterior urethral valves.
7.Abdominal cryptorchidism is associated with all of the following anomalies EXCEPT:
a.transverse testicular ectopia.
b.epididymal anomalies.
c.inguinal hernia.
d.vanishing testis syndrome.
e.polyorchidism.
8.Histologic findings in cryptorchid testes may include all of the following EXCEPT:
a.intratubular germ cell neoplasia, unclassified.
b.absence of Ad spermatogonia.
c.early disappearance of gonocytes.
d.failure of Sertoli cell maturation.
e.reduced germ cell counts.
9.What percentage of undescended testes are nonpalpable at presentation?
a.1%
b.3%
c.10%
d.20%
e.30%
.During laparoscopy, spermatic cord structures exiting an open internal ring ipsilateral to a nonpalpable testis implies:
a.vanishing testis, inguinal exploration unnecessary.
b.vanishing testis, inguinal exploration necessary.
c.intracanalicular atrophic testis, inguinal exploration unnecessary.
d.intracanalicular testis, inguinal exploration necessary.
e.further exploration unnecessary if contralateral testicular hypertrophy is present.
.Advantages of laparoscopic management of an intra-abdominal testis include all of the following EXCEPT:
a.it more accurately assesses the presence or absence, viability, and anatomy of the testis compared with radiographic imaging.
b.it allows for laparoscopic repair of the ipsilateral inguinal hernia when present.
c.it enhances surgical exposure, lighting, and magnification.
d.it allows a greater degree of proximal dissection of the spermatic vessels.
e.it allows diagnosis of associated Müllerian ductal abnormalities if present.
.Which statement is FALSE regarding Fowler-Stephens orchidopexy?
a.It is less commonly associated with testicular atrophy than laparoscopic orchidopexy.
b.It has a lower success rate in patients who have undergone previous inguinal surgery.
c.Blood supply is based on the deferential artery and collateral peritoneal vessels.
d.It should be performed at a similar age as a standard inguinal orchidopexy.
e.It should be considered if the testis is not near the internal ring.
.Which of the following is least consistent with a diagnosis of vanishing testis?
a.Patent processus vaginalis
b.Contralateral testicular hypertrophy
c.Palpable nubbin in scrotum
d.Increased serum follicle-stimulating hormone (FSH)
e.Micropenis
.Lower than expected testicular volume has been associated with all of the following EXCEPT:
a.cryptorchid testes that have descended spontaneously.
b.solitary testes in boys with a vanishing testis.
c.Fowler-Stephens orchidopexy.
d.increased serum FSH.
e.surgery for congenital cryptorchidism at 3 years compared with 9 months of age.
.Regarding epididymal anatomy, which of the following is the most common finding in boys undergoing orchidopexy for acquired cryptorchidism?
a.Detachment of the cauda epididymis
b.Detachment of the caput epididymis
c.Looped epididymis
d.Long looping epididymis/vas
e.Normal anatomy
.All of the following factors may influence the reliability of studies of the efficacy of hormone therapy for cryptorchidism EXCEPT:
a.treatment of boys with retractile testes.
b.initial position of the testis.
c.vanishing testis syndrome.
d.randomization protocol.
e.all of the above.
.A newborn boy presents with a bilateral nonpalpable testes. Next steps in management should be:
a.karyotype analysis.
b.hormonal studies.
c.circumcision.
d.a and b.
e.a, b and c.
.Of the following, which is the least reliable test in confirming the diagnosis of bilateral anorchia?
a.No change in serum testosterone following human chorionic gonadotropin (hCG) stimulation
b.FSH level greater than 2 IU/L at 1 year of age
c.Laparoscopy
d.Undetectable serum inhibin B
e.Undetectable serum antimüllerian hormone (AMH)
.Which of the following is least useful to the provider in determining the diagnosis of retractile versus undescended testes?
a.Observation of testicular position with abduction of the patient's legs.
b.History of prior testicular position provided by the patient's family.
c.Failure of the testis to remain stable in the scrotum with sustained traction on the cord.
d.Warm room and hands.
e.Small ipsilateral testis.
.Which of the following is TRUE regarding spontaneous descent of cryptorchid testes?
a.Spontaneous descent is independent of testicular position.
b.Reascent occurs in 40% of patients.
c.Early descent is more likely in premature boys.
d.Spontaneous descent is unlikely if the scrotum is small.
e.The majority of testes that descend spontaneously do so in the first few months of life.
.The risk of developing testicular germ cell tumor (TGCT) in males with a history of cryptorchidism is:
a.2 to 5 times the risk in normal boys.
b.minimal in boys who undergo orchidopexy in infancy.
c.determined by placental alkaline phosphatase (PLAP) staining in prepubertal testes.
d.similar in the contralateral descended testis.
e.increasing geographically with time.
.All of the following is more common in association with cryptorchid testes, EXCEPT:
a.atrophy.
b.microlithiasis.
c.mature teratoma.
d.ectasia of the rete testis.
e.intratesticular varicocele.
.The following are possible locations of an ectopic testis, EXCEPT:
a.peripenile.
b.perirenal.
c.perivesical.
d.perianal.
e.femoral.
.Levels of all the following hormones peak after birth and fall to lower levels during childhood EXCEPT:
a.luteinizing hormone (LH).
b.FSH.